September 30, 2013
Development Efforts Focused on Next Generation Oligonucleotides to Treat Cancer Capitalizing on Long-standing Experience in TGF-β
February 26, 2013
New direction for trabedersen´s clinical development program and adjustment of organization to meet its current business objectives.